Recently, the drug evaluation center of the State Food and Drug Administration publicized the list of clinically urgent overseas new drugs. The public list includes 7 varieties, including blood system diseases, genetic and metabolic diseases, infectious diseases, nervous system diseases, etc., including innovative drugs for the treatment of influenza A and B. < / P > < p > in 2018 and 2019, the national drug regulatory department has released two batches of overseas new drugs, including 70 kinds of drugs. New drugs included in the clinical urgent need list can apply for marketing directly according to the special review and approval procedures, and enter the rapid evaluation channel. At present, eight varieties in the first batch have been approved for listing.